Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans L Vos

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Thrombosis and Haemostasis|January 10, 2009
Polymorphisms in the protein C gene as risk factor for venous thrombosisElisabeth R Pomp, Carine J M Doggen, Hans L Vos, et al.
The Journal of Biological Chemistry|December 9, 2003
Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679Marijn van der Neut Kolfschoten, Richard J Dirven, Hans L Vos, et al.
European Journal of Internal Medicine|June 6, 2017
Genetic variation in the first-pass metabolism of ethinylestradiol, sex hormone binding globulin levels and venous thrombosis riskBernardine H Stegeman, Hans L Vos, Frans M Helmerhorst, et al.
Neuroepidemiology|October 12, 2011
Prothrombotic gene variants and mortality after cerebral ischemia of arterial originD Martijn O Pruissen, Frits R Rosendaal, Catharina J M Frijns, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 7, 2007
Haplotypes of IL1B, IL1RN, IL1R1, and IL1R2 and the risk of venous thrombosisRick van Minkelen, Marieke C H de Visser, Jeanine J Houwing-Duistermaat, et al.
Plos One|June 8, 2012
Modulation of mouse coagulation gene transcription following acute in vivo delivery of synthetic small interfering RNAs targeting HNF4α and C/EBPαHuma Safdar, Ka Lei Cheung, Hans L Vos, et al.
Thrombosis and Haemostasis|December 2, 2006
Differential effects of the loss of intrachain- versus interchain-disulfide bonds in the cystine-knot domain of von Willebrand factor on the clinical phenotype of von Willebrand diseasePernilla Tjernberg, Hans L Vos, Caroline C Spaargaren-van Riel, et al.
Thrombosis and Haemostasis|September 6, 2003
Frequency of the TAFI -438 G/A and factor XIIIA Val34Leu polymorphisms in patients with objectively proven pulmonary embolismMajida Zidane, Marieke C H de Visser, Marije ten Wolde, et al.
Blood|September 8, 2005
Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levelsShirley Uitte de Willige, Marieke C H de Visser, Jeanine J Houwing-Duistermaat, et al.
Atherosclerosis|July 26, 2005
The plasminogen activator inhibitor-1 (PAI-1) promoter haplotype is related to PAI-1 plasma concentrations in lean individualsMaartje Verschuur, Annemarie Jellema, Else M Bladbjerg, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Thrombosis and Haemostasis|January 10, 2009
Polymorphisms in the protein C gene as risk factor for venous thrombosisElisabeth R Pomp, Carine J M Doggen, Hans L Vos, et al.
The Journal of Biological Chemistry|December 9, 2003
Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679Marijn van der Neut Kolfschoten, Richard J Dirven, Hans L Vos, et al.
European Journal of Internal Medicine|June 6, 2017
Genetic variation in the first-pass metabolism of ethinylestradiol, sex hormone binding globulin levels and venous thrombosis riskBernardine H Stegeman, Hans L Vos, Frans M Helmerhorst, et al.
Neuroepidemiology|October 12, 2011
Prothrombotic gene variants and mortality after cerebral ischemia of arterial originD Martijn O Pruissen, Frits R Rosendaal, Catharina J M Frijns, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 7, 2007
Haplotypes of IL1B, IL1RN, IL1R1, and IL1R2 and the risk of venous thrombosisRick van Minkelen, Marieke C H de Visser, Jeanine J Houwing-Duistermaat, et al.
Plos One|June 8, 2012
Modulation of mouse coagulation gene transcription following acute in vivo delivery of synthetic small interfering RNAs targeting HNF4α and C/EBPαHuma Safdar, Ka Lei Cheung, Hans L Vos, et al.
Thrombosis and Haemostasis|December 2, 2006
Differential effects of the loss of intrachain- versus interchain-disulfide bonds in the cystine-knot domain of von Willebrand factor on the clinical phenotype of von Willebrand diseasePernilla Tjernberg, Hans L Vos, Caroline C Spaargaren-van Riel, et al.
Thrombosis and Haemostasis|September 6, 2003
Frequency of the TAFI -438 G/A and factor XIIIA Val34Leu polymorphisms in patients with objectively proven pulmonary embolismMajida Zidane, Marieke C H de Visser, Marije ten Wolde, et al.
Blood|September 8, 2005
Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levelsShirley Uitte de Willige, Marieke C H de Visser, Jeanine J Houwing-Duistermaat, et al.
Atherosclerosis|July 26, 2005
The plasminogen activator inhibitor-1 (PAI-1) promoter haplotype is related to PAI-1 plasma concentrations in lean individualsMaartje Verschuur, Annemarie Jellema, Else M Bladbjerg, et al.
Pageof 3